ERVW-1 and viral infectious disease: Although the activation and modulation of antiviral responses during viral infection is well characterised, less is known about their impact in the context of vaccination against viral pathogens and in particular, the extent to which innate antiviral surveillance may limit the optimal expression and/or the immunogenicity of the HIV-1 envelope protein (Env), a common candidate immunogen for an HIV-1 vaccine.